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Abstract 
The statistics in relation to non-adherence to prescribed medication make for stark 
reading. Non-adherence to medication is costing European governments an 
estimated 125 billion annually and is contributing to the premature deaths of nearly 
200,000 Europeans every year (IPU, Pfizer and IPA, 2014). The overall aim of this 
project was to introduce a  patient- centred service that would improve adherence to 
prescribed medicine in the writer’s place of work, community pharmacy. 
A literature review was conducted by the writer to identify the advantages and 
challenges associated with patient-centred care, the methods of introducing patient-
centred services were also reviewed. The HSE model was chosen to articulate the 
change in a systematic and structured approach; the four stages included in the 
change model are initiation, planning, implementation and mainstreaming.  
Evaluation of the project included a mixed method approach. This included 
questionnaires, observation and informal interviews. Kirkpatrick’s model of 
evaluation was used to evaluate the educational aspects of the project.  
Overall, the main objectives of the project were achieved. The change process 
resulted in an improvement in patient engagement and medicines adherence. 
Pharmacists welcomed the opportunity to develop their professional role and 
counselling skills. The “know your medicines” service provided an opportunity for 
pharmacist and patient collaboration. Moreover, the service was perceived as 
beneficial to patients and will be further disseminated to the entire organisation 
before the end of 2015.  
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1. Introduction 
The purpose of this organisational project is to improve the rate of non-adherence to 
prescribed medication through the introduction of a patient-centred service. 
According to the World Health Organisation (WHO, 2003) 50% of patients fail to 
adhere to prescribed medicine when long term medication is prescribed.  
Furthermore, a report into non-adherence to medicines was published in 2014 by 
Pfizer Ireland, the Irish Pharmacy Union, and the Irish Patients Association.  The 
report highlighted forgetfulness, side effects and patient perception as the most 
common reasons for non-adherence to medication. The report also revealed that the 
factors which lead to patients taking their medication as prescribed are; the patient 
engaging with their doctor regularly, understanding their condition and having a good 
understanding of the medication (IPU, Pfizer and IPA, 2014). Given the above data, 
the writer felt it important to look at the area of medication adherence within their 
area of employment, community pharmacy. 
 
This change project is titled “Know your Medicines” and was carried out in four 
community pharmacies across Dublin and Limerick. The project provided patients 
with an opportunity to discuss their medication and to acquire the appropriate advice 
and information from their pharmacist. The pharmacies are part of a large pharmacy 
group that currently consists of eighty-seven pharmacies. The individuals involved in 
the project are four community Pharmacists, the care services co-ordinator, (The 
writer) and the health strategy manager. Given the writer’s contacts within a wide 
demographic, they decided to use this to their advantage and based the change 
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project across the Dublin and Limerick area. The change initiative commenced in 
September 2014 and finished in March 2015. 
This dissertation will be presented in five chapters. In this chapter, the writer 
highlights the background and rationale for carrying out the organisational 
development project. The associated aims and objectives are outlined, and the 
writer’s role in the project will be explained. In chapter two, the main themes related 
to the literature review will be extracted from selected articles. The review themes 
will provide a critique of the literature and further substantiate the rationale for 
change. Chapter three explores the methodology and methods used as part of the 
organisational development process. The relevant steps for change are structured 
using the Health Service Executive (HSE) change model. Chapter four discusses the 
project evaluation through qualitative and quantitative data collection and analysis. 
Finally, Chapter five reviews the findings from the organisational development 
project. This chapter will include organisational impact, strengths and limitations of 
the project and conclude with the overall findings of the change project. 
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1.2 Organisational Context 
An improvement concerning medication adherence would not only have a positive 
impact on health outcomes, the organisation would also benefit financially from 
repeat prescription business. While the writer’s primary aim was to improve patient- 
centred care and adherence to medication, this aspect encouraged the organisation 
to further support the project. However, the attitudes, behaviours and practices of the 
Pharmacists would have to change to ensure the new process was feasible. The 
new process would translate to an increase in pharmacist and patient interaction, 
hence the “know your medicines” service would change the process through which 
pharmacists and patients engage.  
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The writer was aware that it would require “buy-in” from pharmacists and patients for 
the project to succeed. The questionnaire that was completed by the patient and 
pharmacist during the “know your medicines” service established the patient’s actual 
use of medication and identified areas of ineffective use. The main stakeholders 
were the pharmacists; patients; superintendent pharmacist; and the health strategy 
manager.  
The organisation agreed to the implementation of this project in four community 
pharmacies which meant an increase in the key stakeholder’s workload across the 
participating pharmacies.  During the pilot phase, the writer collaborated with the four 
community pharmacists participating in the project and reported data to the health 
strategy manager within the organisation. 
The purpose of this data collection was to ascertain the value of adherence 
questionnaires. The expected outcome was an increase in medicines adherence 
through an improvement in patient education, advice and counselling. 
Additionally, the percentage of repeat prescription items was also measured. The 
target had been set at a 2% increase in prescribed items. On completion of the pilot, 
a business case for a full organisational roll-out was presented to members of the 
senior management team. This included the health and financial benefits of the 
service, estimated budget and resources required to complete the project and the 
anticipated time frame. The organisation currently consists of eighty- seven 
pharmacies. 
 
Ethical Approval  
The Royal College of Surgeons in Ireland (RCSI) ethical recommendations 
contained in the dissertation guidelines was referred to prior to commencement of 
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the project. The change project was implemented within the writers place of work; 
therefore the writer sought approval to carry out the change from the superintendent 
pharmacist employed by the organisation. In this circumstance, ethical approval was 
not required by the organisation. In adhering to the RCSI ethical guidelines, the 
writer submitted a letter that confirmed such to the RCSI ethics committee.  
This organisational change project was in line with the pharmacist’s legal obligation 
to ensure each patient had been offered sufficient advice and counselling on the use 
of their medication (Retail Pharmacy Business Regulations, 2008). As this 
organisational project was conducted in collaboration with the pharmacist in their 
professional role, ethical approval was not a requirement. 
According to Cohen et al. (2007), questionnaires can be persuasive, intrusive, and 
time-consuming for the participant; therefore the writer outlined clearly that the 
service was entirely optional for patients. The data obtained from the questionnaire 
was securely stored at all times and was only accessible to the participating 
pharmacists and the writer. Furthermore, all participating patients provided their full 
consent by signing a consent option contained in the “know your medicines” form.  
 
1.3 Rationale for carrying out the change 
The regulatory requirements contained in the pharmacy business regulations (2008) 
outline that prior to the dispensing of each prescription and prior to the supply of 
medicinal products concerned, the pharmacist must review the prescription 
concerning the pharmaceutical and therapeutic appropriateness.  
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Furthermore, the document also outlines that each patient should have sufficient 
information and advice for the proper use of the prescribed medicinal product and 
shall offer to discuss such with the patient or the carer of the patient. 
While this is a regulatory guideline and best practice, it is not always standard 
procedure in community pharmacies. Through qualitative analysis, the writer has 
observed the supply of medication to patients without appropriate advice and 
counselling. The explanation for this could be the added pressure associated with 
working in a community pharmacy in recent years. Community Pharmacies have 
been affected by considerable cuts in fees paid to pharmacists by the HSE through 
the Financial Emergency Measures in Public Interest (FEMPI) Act, 2009. This has 
led to the shift from a margin model to a volume model that has led to an increase in 
workload and a decrease in resources. The introduction of this change project will 
not only improve adherence to medication, it will also encourage pharmacists to 
develop their professional role and skills through an increase in patient engagement. 
A similar service was added to the NHS pharmacy contract on 1st of October 2011. 
The service provides support for patients with long-term conditions and newly 
prescribed medicines to improve medicines adherence. It was agreed after the pilot 
period that this service would be continued into 2014/15. NHS employers envisaged 
that the successful implementation of this service would indeed develop the role of 
the pharmacist through increased patient engagement and also an improvement in 
patient adherence that will generally lead to improved outcomes (PSNC Main site, 
2014). The NHS version further substantiated the rationale for change and provided 
the writer with a tangible benchmark.   
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1.4 Aims and Objectives 
1.4.1 Aim:  
The aim of this development project is to improve low adherence to prescribed 
medication through improved advice and counselling. This will enhance treatment 
outcomes and ensure the patient has been given the appropriate information on the 
use of their medicines.  
 
 
  1.4.2 Objectives: 
1. To gather quantitative and qualitative data through a “Know your medicines” 
questionnaire. This will inform through analysis; process and behavioural 
changes that will lead to an improvement in patient care.  
2. To encourage repeat prescription customers to return to the organisation. The 
target has been set at a 2% increase in prescribed items. 
3. To improve the rate of non-adherence by changing the process in which 
pharmacists engage with patients.  
4. The questionnaire will be rolled out to four pharmacies before the end of 
January 2015 as a trial project.   
 
1.5 Role of the student in the organisation and project 
The writer is the care services co-coordinator for a large pharmacy group in Ireland. 
Their role as part of the care services team is to implement medicines management 
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systems in managed care settings and to review their effectiveness concerning 
regulatory requirements and safety continuously. 
This project is an extension of their role and directly linked to the care services 
strategy. The writer directed this project during each stage and ensured sufficient 
support was provided to those involved, in this case, pharmacists and patients. This 
support included engaging and regularly communicating with the key stakeholders 
and taking their feedback into account. This allowed the writer to make any 
necessary improvements and amendments during the pilot phase so that an entire 
organisational roll-out would be efficient and practical.  The project is directly related 
to patient-centred care which is an area the writer is immensely committed to. 
 
 
1.6 Summary and Conclusion 
In summary, the consequences of non-adherence to prescribed medicines are 
reduced health outcomes and added healthcare costs. This service will improve 
patient knowledge and adherence through verifying the patient’s actual use of 
medication and resolving inappropriate use. 
It will also provide an opportunity for the patient to discuss any concerns or 
apprehensions they may have, hence developing the skills and role of the 
pharmacist. This is a fundamental factor in ensuring the health-care professional is 
providing an adequate contribution to the patients’ welfare and maintaining their duty 
of care. Moreover, if adherence to medication improves prescription items will 
increase. Thus, impacting positively on the organisations prescription item revenue.  
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2. Literature Review 
2.1 Introduction 
Before commencing an organisational change project, the writer needed to complete 
a literature review of the topic area. 
The purpose of the literature review was to identify, analyse and critique the 
literature associated with such a change. This information provided the writer with 
the current research findings and limitations in their selected area.  After in-depth 
research of the articles stored in the Emerald database, the main areas of focus 
were identified as the following: 
 Patient Engagement 
 Patient Education and the effect on medication adherence 
 Health Coaching 
The method in which the writer carried out the search is discussed below under the 
heading search strategy.  
 
2.2 Search Strategy 
The emerald database was chosen as the primary research tool for articles as it 
offered a comprehensive list of associated literature. Google scholar was also used 
as a research tool as it provided a broad search of several databases. The initial 
search reviewed journals wrote after 2009. However, the writer found this information 
limited so decided to broaden the search to articles published after 2004. Older 
references found in the bibliographies of the selected articles were also reviewed; 
this allowed the writer to identify seminal articles in this area. The search terms and 
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keywords used included; ‘patient engagement, ‘compliance’, ‘adherence’,  ‘patient 
education’, ‘community pharmacy’, ‘medicines management’, ‘patient -centred care’. 
This is a review of the literature that encompasses and evaluates the transition to 
patient-centred care. The inclusion criteria for this review comprised of systematic 
reviews, meta-analysis reports, and randomised controlled trials. In particular, the 
review focuses on the rationale behind the change to NHS community pharmacy 
contracts in 2005, which sought to reward more patient-centred services (Latif, 
Pollock and Boardman, 2011). The writer also looked at literature outside the UK, 
studies published in Finland, the Netherlands and Canada was also reviewed. The 
subsequent themes are discussed by the writer under the below headings, patient 
engagement, patient education and health coaching.  
  
 
2.3 Review Themes 
2.3.1. Patient Engagement  
“Engaging patients in their healthcare and encouraging people to take responsibility 
for protecting their health are now seen as the best way to ensure the sustainability 
of health systems” (Coulter, 2006). 
Patient engagement is not merely linked to patient participation in decision -making; 
patient engagement refers to working collaboratively with the individual on a 
partnership level (Gruman et al., 2010).This relationship requires understanding 
rather than solely an information seeking activity; which the literature defines as 
paternalistic (Greenall, 2006). Furthermore, patient engagement encourages patient 
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-centred care which is integral to improving outcomes and the overall quality of care 
(Luxford, Safran and Delbanco, 2011). 
In contrast, however, the literature highlights the correlations between patient 
engagement and improved patient outcomes but also emphasises the absence of 
scientific evidence and relevance to excellence in clinical care (Coulter and Ellins, 
2007).  
A systematic review carried out over 25 years verified the correlations between 
communication interventions and improved health outcomes. The studies suggest 
that patients need to feel that their complaint has been discussed completely and 
that they are actively contributing to decisions about their care (Stewart, 1995). In 
addition, the studies reviewed indicate that effective communication and 
engagement not only impact on the emotional health of the patient but also on 
“symptom resolution and physiologic status” (Stewart, 1995). 
However, critics of shared decision- making would argue that too much information 
has an adverse effect on outcomes, and those uncertainties inherent in medical care 
could be harmful (Coulter, 1997).While engaging patients in the level of care 
delivered to them may lead to improved outcomes, the ultimate responsibility for the 
care they receive should remain with the healthcare professional (Davis et al., 2007). 
Evidence from the literature suggests that although patients wish to be involved in 
their care and treatment options they ultimately rely on the healthcare professional to 
make decisions on their behalf (Levinson et al., 2005). Effective patient engagement 
encourages the health care professional to make a decision that encompasses the 
values and wishes of the patient. The relationship between the healthcare 
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professional and patient should be non-hierarchical and based on mutual respect so 
that common goals can be achieved (Coulter, 1999). 
A study carried out in association with the Picker Institute revealed that while the UK 
are committed to patient-centred care, data results were less positive in comparison 
to other countries involved. Data collected through the use of a survey in the UK, 
Australia, Canada, New Zealand, Germany and the USA was used to evaluate 
performance in relation to Patient engagement. This study concluded that the 
changes made to UK policies in recent years have not had the anticipated effect on 
professional/patient relationships (Coulter, 2006). 
A review of the literature highlights the various barriers to patient engagement; from 
both a professional and patient perspective. A study published in 2008 examined the 
attitudes of community pharmacists towards medicines use reviews. While the article 
highlighted the value of pharmacists engaging with their patients; it also 
acknowledged various barriers. These included the time to complete a medicines 
review, and also the availability of a suitable consultation area (Latif and Boardman, 
2008).  From a patient perspective, “a lack of interest” and “time” is noted as a 
barrier to effective engagement and appropriate counselling (Albekairy, 2014).The 
literature reasons that healthcare professionals must develop their behavioural skills 
and health coaching abilities to engage patients in their care (Barnett and McDowell, 
2012). 
 
Patient Education  
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2.3.2. The effect on medication adherence: 
Inadequate adherence to prescribed medication is common and often leads to an 
increase in healthcare expenditures, hospitalisations and reduced quality of life (IPU 
Pfizer IPA, 2014).Patients are more likely to adhere to a medication when they 
understand the implications of non-adherence and when they believe adherence will 
improve their condition. Hence, healthcare professionals play a crucial role in helping 
patients to understand their condition, the advantages of treatment and addressing 
any apprehensions (Bourbeau and Bartlett, 2008).  
Moreover, studies show that the way in which information is communicated to 
patients contributes to their level of understanding and the likelihood of adherence. A 
meta-analysis published in 2009 highlighted the correlation between clinician 
communication and adherence. There was a 19% higher risk of non-adherence 
among patients whose clinician did not explain treatment appropriately (Haskard 
Zolnierek and DiMatteo, 2009).   
More recently, a study carried out in Finland addressed the impact of patient 
education on self- management. Findings from the study highlighted the correlation 
between patient education and patient-centred care. In the case of chronic 
conditions, patients will have a lifelong dependency on healthcare and medication. 
Therefore, there should be an emphasis on patient education so that the patient has 
the knowledge and understanding to adapt their behaviour to their condition 
(Mikkonen and Hynynen, 2012). However, the writer acknowledged that this study is 
only reflective of a small sample size, so the results are not without limitations.  
A more comprehensive review published by Vermeire et al. (2001) outlines that 
adherence is a complex problem, especially for patients with chronic conditions. 
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While the findings outline the link between professional and patient education as an 
important factor in compliance; it was also noted that this aspect is difficult to 
evaluate. 
Nonetheless, a randomised trial conducted by Lee et al. (2006) measured the effect 
of a pharmacy- led education programme on adherence to medication associated 
with continuing disease. The trial focused on 200 patients who were over 65 and 
were taking at least four medications. This initiative was carried out from 2004 to 
2006 and included basic medication education and pharmacist intervention. This 
included standardised education around medication, regular pharmacist follow-up 
and dispensing medication in a monitored dose pack. Baseline data was retrieved 
after two months and again after six months, the results showed an increase from 
61.2% adherence to 96.9% (Lee, Grace and Taylor, 2006). This study reinforces the 
correlation between patient education and adherence. Conversely, looking at this 
study from a critical point of view, sustainability seems to be the difficult part to 
evaluate. In this particular paper, adherence dramatically improved but only for the 
duration of the project. The literature illustrates the importance of health coaching in 
encouraging sustainability of appropriate care and adherence to treatment (Greenall, 
2006).  
 
2.3.3. Health Coaching 
“Health Coaching can be defined as helping patients gain the knowledge, skills tools 
and confidence to become active participants in their care so that they can reach 
their self-identified goals” (Bennett et al., 2010). 
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The literature describes Health Coaching as a collaborative paradigm that 
encourages individual self-management. Self-management is essential for patients 
to extend their treatment and health- care into their everyday lives (Bennett et al., 
2010). 
This requires a substantial level of support from the professional as patients and 
families must be trained to manage their care. The patient should understand the 
various aspects of self- management; using the medication correctly, monitoring 
important symptoms, dietary changes and adjusting to physical limits. The literature 
summarises that this will enhance the coordination of care, improve health outcomes 
and reduce hospitalisations (Bodenheimer et al. 2009). 
A randomised trial published in 2003 analysed the effects of patient coaching on 
patients commencing with anti-depressants. The aim was to analyse psychological 
symptoms and adherence by means of a coaching programme by community 
pharmacists. The results presented a significant reduction in anxious and depressive 
symptoms; analysis showed that the intervention was particularly successful in 
patients with a lower education status. They concluded that pharmacist coaching is 
an effective way to improve adherence, and this approach is acceptable to patients 
(Brook et al., 2003). A collective process bridges the gap between evidence -based 
Medicine and “the real world” (Vale et al., 2002).  
This approach has become part of the most recent changes to NHS policies. 
Structured education programmes have been shown to add significant value to 
health outcomes (Deakin, 2011). The X-Pert insulin programme is provided to 
patients over a six -week period and incorporates patient education and self-
management skills. The implementation of this project has shown an improvement in 
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diabetes self-management, resulting in the Glycaemic control and considerable 
savings to the NHS (Deakin, 2011).  
Similarly, a study carried out by Diamond and Chapman (2001) found that 
intervention programmes that incorporate patient education and health coaching can 
influence symptomatic improvement and appropriate self-management skills.  This 
study measured the effectiveness of an asthma clinic day that was implemented 
across a chain of community pharmacies in Canada; the design included the use of 
a questionnaire, individual patient counselling and education. In the 4080 patients 
assessed, baseline data revealed 22.2% of patients were using inadequate inhaler 
technique. 16.4% were using a short- acting beta2 agonist excessively, and 21.0% 
were not using an inhaled corticosteroid as needed. Thirty days after the 
intervention, patients reported an improvement in asthma symptoms. The self-
management behaviour was more controlled with a significant increase in the use of 
preventative medication (Diamond and Chapman, 2001).  
 
However, concerning the cost effectiveness of a pharmacy intervention programme, 
a Danish study by Bosmans et al. (2007) found that the increase in adherence was 
not significant enough to invest in the additional resources required.  
Nevertheless, a report published by Ovretveit (2011) advocates that although 
evidence in this area is limited, improvement initiatives can decrease costs to the 
healthcare providers and improve the overall quality of care. The research argues 
that these initiatives require careful planning, expertise and high -quality 
implementation (Marshall and Ovretveit, 2011).  
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2.4  implications for the project 
The literature review provided a comprehensive overview of patient-centred care 
which further substantiated the rationale behind this organisational change project. 
The writer considers the literature in favour of patient centred care to be more 
convincing.It is apparent, patient engagement, patient education and health coaching 
are distinctly linked in and collectively lead to improved patient outcomes. 
However, in many of the studies reviewed; intervention programmes led to enhanced 
health outcomes for the duration of the project but failed to promote sustainability on 
completion. Many led to an improvement in patient education and patient 
engagement but failed to provide the patient with the necessary self-management 
skills for future sustainability. The literature also revealed the perceived barriers to 
patient-centred care; these factors including time and lack of patient interest will be 
taken into account prior to the implementation of this project so that the success of 
the change is not hindered. 
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2.5 Summary and Conclusion 
The writer conducted a literature review of patient –centred care, this review 
identified patient engagement, patient education and health coaching as the main 
review themes. In summary, the findings from the literature promote the progression 
of patient-centred care initiatives. When care is focused on the patient, the overall 
quality of care is improved. The review has also helped to form the change process 
by providing the writer with the essential information to introduce such a change 
within their organisation. The following chapter, chapter three provides an overview 
of the methodologies used during the change process. The process is structured 
using the HSE model of organisational change.  
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3. Change Process 
3.1 Introduction 
This organisational change project is concerned with improving medication 
adherence in a community pharmacy setting, identifying reasons for non-adherence 
and ineffective use of prescribed medicine through the introduction of a patient-
centred service. In discussing change efforts, Kotter (2005) outlines that 70% of 
change initiatives fail. Further to this, the limited success of these change efforts may 
be due to the absence of a change model (Leeman, Baernholdt and Sandelowski, 
2007).It is apparent, even the best change efforts require a model to guide and 
articulate the change into practice (Cohen, 2005) 
In this chapter, the writer will provide an overview of the methodology and methods 
used as part of the change project. The writer will describe the various phases 
through the application of the Health Service Executive (HSE) model of change. The 
phases included in this model are initiation, planning, implementation and 
mainstreaming. The rationale for deciding on this particular change model will also 
be provided. 
 
3.2 Organisational Change 
Change is an unavoidable element in all organisations.Businesses must adapt and 
respond to new challenges so that they continue to grow and cope with external 
factors (Kotter, 2009). According to the World Health Organisation (2000), change is 
particularly significant in healthcare organisations; despite constraints and fewer 
resources patient expectation has increased, and there is a greater demand for 
higher quality care. 
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For the most part, change is required due to necessity or in response to problems 
(Gittins and Standish, 2010). Irrespective of the need for change, there must be an 
internal desire and vision for change. Kotter (2005) refers to this as creating a sense 
of urgency. He contends that change should have a structured approach that 
requires time, preparation and various phases. Regardless of how well planned 
organisational change is the success of the project may be hindered if the culture is 
disregarded (Werkman, 2009).Culture is a core element in every organisation as it 
reflects the common behaviours and beliefs of those employed there (Parmelli et al., 
2011). Therefore, if these aspects are overlooked during the change; the context of 
the change process may be misinterpreted by the change agent. Hence, employee 
resistance and lack of change sustainability is probable (Anders and Cassidy, 2014). 
 
3.3 Change model selected for this project 
In 1947, Kurt Lewin created one of the original models of change. He recognised 
three stages of change; unfreeze, change and refreeze. Kotter (1996) further 
developed Lewin’s model with an eight-step model. The model consists of eight 
steps and  commences with creating a sense of urgency, building a guiding team, 
creating the vision for change, empowering staff, creating short- term wins, staying 
persistent and making the change permanent. Kotter contends that skipping any of 
these stages only creates the illusion of speed but ultimately never produces the 
desired outcome (Kotter, 1995). While both models have apparent similarities, 
Kotter’s eight step model provides more comprehensive guidance and structure for 
implementing change. Kotter puts a vast emphasis on the importance of the team, 
communicating the vision and celebrating short -term wins. 
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Similarly, the Senior and Swailes OD model of change (2010) incorporates every 
part of the organisation and the individuals employed there. While creating a vision 
for the future is also a key component in this model, the emphasis focuses on the 
change agent. The change agent is at the centre of the model and is responsible for 
driving the change forward. Thus, in the context of this model the change agent is 
ultimately responsible for the success or failure of the change.  
Although the writer appreciates the importance of the change agent during change 
they also recognise the complexities of healthcare. The Healthcare sector tends to 
be more reactionary than strategic as it is forced to respond to external factors. 
Consequently, in the context of healthcare, change is not linear; it is a continuous 
and adaptive process that can be affected by people and external influences (HSE, 
2008).For this reason, the writer resolved that the HSE model of change would be 
the most suitable model to guide their project. To further confirm that this model was 
the most appropriate choice, the writer performed a SWOT analysis associated with 
such. (Appendix 1) The Health Service Executive Model (HSE) consists of four main 
elements, Initiation, Planning, Implementation and Mainstreaming. Each category 
also contains sub-categories that offer further clarity and guidance. 
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Figure 1: HSE change mode 
In the remainder of this chapter, the writer will elaborate on the various stages of the 
project using the structure of the HSE model of change. 
 
3.4 Initiation Stage 
3.4.1 Preparing to lead the change  
The first stage of the HSE model is initiation; during this stage the writer performed 
various analytical tools including SWOT, PEST, Stakeholder and a Force Field 
Analysis. The data from these tools identified the drivers and resistors for change 
and also highlighted the possibility of successful change. A SWOT analysis is 
commonly used for analysing strengths and weaknesses; this information can then 
be used to develop strategy and aid in decision-making (Kajanus et al., 2012).  In 
this case, the SWOT (Appendix 2) was performed to identify areas for action. The 
paramount strengths associated with the project included senior management 
  
32 
 
support and the NHS version. The writer used both factors to reduce the effect of 
identified weaknesses such as time to complete the questionnaire and conflicting 
projects. As this project was supported by senior management; the writer could 
make it a priority for the pharmacists involved. The NHS version was advantageous 
in the design phase and also in providing evidence of project value. This was used to 
influence key stakeholders and to reduce resistance. 
The PEST tool was used to analyse external factors such as political, external, social 
and technological. (Appendix 3)The PEST analysis was a paramount element in the 
preparatory stages as it highlighted the key drivers for change and outlined 
environmental factors.According to (Johnson et al.), these aspects have a high 
impact on the success or failure of the change project. The PEST analysis revealed 
that there was an immense opportunity to create a patient- centred service that 
would have a positive impact socially and economically.  
The Force Field Analysis (Appendix 5) outlined the key drivers for and against 
change. While the key drivers deemed more significant than the forces against 
change, the forces against change could not be disregarded. The writer 
acknowledged that forces, not in favour of change such as the time to complete the 
questionnaire, and pharmacist resistance could have an unfavourable effect on the 
project. These factors were also considered significant in the literature review. To 
reduce the effect of these resistors, the writer put the focus on pharmacist 
participation in the planning stages. It is imperative that managers engage and 
include clinicians in organisational change; interaction is required from both groups 
in order to succeed (Bååthe and Erik Norbäck, 2013).   
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Planning Stage 
3.4.2 Building Commitment  
The planning stage of the project involved bringing the key stakeholders together to 
present a business case and communicate the change. The writer attended the 
monthly pharmacist forum to present data from the force field analysis. This was a 
beneficial tool as it included the key drivers for change, and the overall aim and 
benefits of the “Know your Medicines” service. Kotter (2010) emphasises the 
importance of communicating the vision for change and getting buy-in from those 
involved, he maintains that if the change is not communicated effectively, the change 
will not succeed. However, the writer acknowledged the threat of over-         
communication. The objective of the pharmacist forum meeting was to examine the 
barriers and achieve buy- in from key stakeholders. Johnson, (2010) contends that 
these groups can create over analysis and debate rather than the delivery of change. 
Hence, the writer deemed the force field analysis highly valuable as it outlined the 
key drivers for change and created a framework for the meeting.      
The pharmacist forum was a suitable platform to present the questionnaire as it was 
a non-formal setting that encouraged open discussion and feedback. Although a 
draught version of the adherence questionnaire was presented, the writer sought 
pharmacist advice on the final questionnaire design and detail of the change. The 
writer hoped that by including the key stakeholders in the design and development of 
the project, they would gain their expertise and build commitment. According to 
Kotter (2008) employee participation is vital during the design and implementation 
phase, this will build commitment and avoid resistance. It was also anticipated that 
this would promote effective change during the transitional period and promote 
sustainability (Narine and Persaud, 2003). 
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Determining the detail of the change: 
Overcoming Resistance: 
The detail of the change was negotiated and prepared over several weeks. The 
writer continued to use the pharmacist forum meetings to engage with the 
pharmacists involved; this deemed valuable in deciding on the final version of the 
questionnaire (Appendix 7) and preparing for the roll out. 
Conversely, pharmacist resistance was still evident at these meetings. According to 
Kotter (2008) it is extremely common for managers to encounter some form of 
human resistance during organisational change efforts, and they must assess the 
reasons why. While the consensus was in favour of the service, time to complete the 
questionnaire was still an apparent obstacle. Pharmacists also raised concerns 
concerning patient interest; they believed the level of interest might not be high 
enough to support a successful project.  
Further to this, the writer acknowledged that the project required a change to the 
current culture; although time and lack of patient interest were outlined as resistors 
to change. The writer recognised that the core cause of resistance was related to the 
anticipated change in culture. Culture is not as receptive to change in the way new 
processes are (HSE,2008). Hence, it was imperative as a change agent to manage 
the general feeling of uncertainty and understand their resistance. 
However, the writer did not consider this reaction to be entirely negative as 
according to Ford (2008), resistance to change can be positive if it leads to open 
conversation and discussion. While the conversations were not completely positive, 
the writer acknowledged that this was an indication of progress; and that these 
responses were reflective of engaged participants (Robbins, 2005). 
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For many pharmacists, managing their current workload leaves them with little time 
for intervention and reflection. Additionally, unlike other healthcare professionals, it is 
not as common for pharmacists to engage in note taking. Therefore, for the change 
to be successful; the participation, engagement and commitment of pharmacists 
were highly significant in changing the delivery of care (Werkman, 2009). 
The management of work- related stress: 
It was, therefore, necessary for the writer to consider the participants’ current 
workload and to avoid added strain that could ultimately lead to change “burn-out”. 
According to Handy (1993), one of the primary situations that lead to stress in 
organisations is conflicting projects. It was, therefore, imperative for the writer to 
consider the consequence of added work stress and to manage the situation 
appropriately. Though, according to Grandey (2000), not all work related stress is 
negative; many individuals may use stress to perform to their maximum potential. 
 In contrast, however, while this is advantageous for the manager, employees are 
likely to perceive stress as unfavourable (Robbins, 2005). With this in mind, the 
writer decided to adopt a supportive management style, this approach according to 
Dubrin (2010) “enhances morale when group members work on stressful tasks” 
p141. While certain amounts of stress may lead to work alertness and competence 
to react suitably.The long- term impact of stress will eventually impede productivity 
and performance will decline (Handy, 1993; Robbins, 2005). 
Hence, in order to gain buy- in, the writer offered to attend each pharmacy and assist 
with the pilot. This collaborative approach encouraged additional engagement and 
assisted in persuading the group towards the same goal. Gallup (2014) describes 
this leadership approach as visioning; this creates a convincing picture of the future 
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that inspires others in the organisation. In this circumstance, the writer wanted the 
stakeholders to envision how valuable this service was to patients, and that the time 
it required to complete each questionnaire was worthwhile. In contrast, however, Gill 
(2003) would argue that an over- emphasis on management and an absence of 
leadership may lead to the failure of a change initiative; he argues that although 
management is important; leadership makes the difference in the delivery of change. 
However, in this instance the writer considered this approach to be the most 
appropriate as they wanted to take a supportive approach to change. It was agreed 
that a collective pilot would take place in each pharmacy prior to implementation.   
Piloting 
It was paramount that the writer piloted the questionnaires. Through piloting the 
questionnaires beforehand, it gave the writer increased insight into problem areas for 
the participants, in this case, pharmacists and patients. It was also necessary for the 
writer to test the questionnaire for validity and practicality. According to Marshall, 
(2005) piloting is essential before the questionnaire is administered to the research 
sample, reliability and validity of the questionnaire needs to be consistent and 
dependable. However, according to van Teijlingen & Hundley, (2002) although 
piloting may increase the likelihood of success, it does not guarantee success in the 
main project. It was, therefore, essential that the writer considered this and did not 
become complacent during the implementation stage.   
Communicating the pilot- project  
Once the pilot dates were agreed, the writer formulated the communication strategy 
for patients. It was imperative that patients were aware of the “Know Your Medicines” 
service. It was agreed that a window display would be used to highlight the 
opportunity for patients to discuss their medication with their pharmacist.This was 
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designed by the writer and health strategy manager. (Appendix 6) It was also agreed 
that the pharmacists involved would actively promote the service and approach 
patients with a probability for non-adherence to prescribed medication.  
Structured Questionnaires 
The design and content of the questionnaire were based on the Belief in medicines 
questionnaire (BMQ). This questionnaire is a flexible tool that can be used to assess 
beliefs and concerns in relation to the use of prescribed medication. The patient 
results are scored using a five-point Likert scale that provides a score ranging from 
5-25. High scores equal high perceived sensitivity to adverse effects of medication 
and, therefore, a likelihood to be non-adherent (Horne, Weinman and Hankins, 
1999), (Neame, 2005). Similarly, The New Medicines Service launched by the NHS 
in 2011 was based on this concept so was also referenced during the design phase. 
Thirty questionnaires were distributed to patients during the pilot; the questionnaires 
contained a Likert scale of options such as always true and never true. The benefit of 
using this style of research is the results are easily quantifiable and subjective to 
mathematical analysis (Muijs, 2004). However, the writer was conscious of the data 
gathered through this medium, as Loxley (2010) states that a Likert scale method 
“has the potential for bias”. Therefore, it was paramount that mixtures of quantitative 
and qualitative methods were used to collect information from the patient. With this in 
mind, it was decided that the questionnaires would not be self-administered. The 
following figure represents the scoring scale on the “know your medicines” 
questionnaire.  
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Figure 2: Questionnaire scale 
3.4.2 Developing the implementation plan 
Pilot Results 
The results of the pilot were communicated at the following pharmacist forum 
meeting. With regard to pilot data, the questionnaire results correlated with the report 
published in 2014 by Pfizer Ireland, The Irish Pharmacy Union, and the Irish 
Patient’s Association. Similarly, side effects, forgetfulness and a lack of 
understanding were the most common reasons for non-adherence in the pilot 
sample. Moreover, there was a 100% participation rate from those asked to 
complete the questionnaire. This result challenged pharmacist perception of patient 
interest and also various articles that maintained the lack of patient interest as a 
threat to adherence questionnaires (Latif and Boardman, 2008) (Albekairy, 
2014).However, the writer is aware that their pilot was only reflective of a small 
sample size so is not without limitations.  
The writer used this data to persuade and influence those involved that this was 
indeed a worthwhile service and could improve medicine adherence and, therefore, 
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patient health outcomes. Nevertheless, the pilot was not without flaws and the writer 
highlighted these at the meeting so that a more practical and efficient implementation 
could be considered.  
As the time to complete the questionnaire was still a concern, it was decided to 
create a more structured approach. Data from the pilot revealed asthma patients 
would particularly benefit from additional support from the pharmacist.There was a 
high percentage of patients using their inhalers incorrectly and experiencing side 
effects. Hence, it was decided that the questionnaire would be used to improve the 
rate of non-adherence in this one cohort. It was agreed at the forum that this 
approach would be easier to implement and evaluate.  
3.4.3 Implementation 
Implementing Change 
At this stage of the change process, the agreed actions determined in the planning 
stage should be implemented, and the manager should provide clarity around 
commencement dates and sufficient communication with staff and service users 
(HSE, 2008). According to Nielsen and Randall, (2009) even the most promising 
change initiatives have been unsuccessful as a result of poor implementation, 
managers should be available to assist in change and create a supportive 
environment. 
With this in mind, the writer engaged again with several key stakeholders to ensure 
the actual implementation was communicated and managed appropriately. This 
involved meeting with the superintendent pharmacist to discuss the structure and 
detail of the “know your medicines” clinics and then communicating such to the 
pharmacists involved. A window display and pharmacist recommendation were used 
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to communicate the service to asthma patients; this approach was undertaken as it 
had been successful in the pilot phase.  
On the day of each clinic, the writer demonstrated their support by attending the 
pharmacy and meeting with the patients involved. The questionnaire was completed 
to determine the patients’ probability to be adherent, the pharmacist then invited the 
patient to demonstrate their inhaler technique and discuss their medicines. This 
allowed the writer and pharmacist to ascertain the patients’ actual use of medicine 
and provide appropriate advice and counselling to resolve areas of concern and 
ineffective use.  On completion, a patient review meeting was set up for March. This 
provided the writer with an opportunity to evaluate the success of the service. 
Questionnaire one and two were compared to measure the impact of patient 
counselling and advice. Further detail on the evaluation will be provided by the writer 
in chapter four. 
Sustaining Momentum 
At this stage, the first phase of implementation was complete, and review meetings 
were set up to review the patients’ progress. As the follow- up meetings were not 
due until the following March (eight weeks post initial questionnaire) it was vital to 
maintain enthusiasm amongst stakeholders and patients’. Concerning sustainability, 
staff involvement and attitude towards the change are fundamental factors (Doyle et 
al., 2013).Hence, It was imperative that communication was consistent and those 
involved were given clarity on their roles (HSE, 2008). With this in mind, the writer 
regularly communicated with the pharmacists’ involved to reinforce the importance of 
the review meetings, and to ensure they had the support and resources to complete 
them. The writer also advised the pharmacists’ to communicate with their patients’ in 
advance of their review meeting to ensure they attended for follow-up.  
  
41 
 
3.4.4 Mainstreaming 
Making it “the way we so our business”. 
This stage focuses on the success of the change initiative and sustaining new ways 
of working (HSE, 2008). With this in mind, the writer acknowledged the significance 
of engaging with those involved and congratulating them on their efforts towards 
change. Kotter (1995) refers to this as celebrating short- term wins. The writer 
contacted each employee individually thanking them for their time and participation 
with the asthma clinics. This was integral in preventing the loss of momentum and 
encouraging participants to remain engaged in the change process (Kotter, 1995). 
 A meeting was also arranged to gather their feedback in relation to moving forward 
with the project. When leading the organisation to sustainable change, it is 
necessary to consider the balance between the needs of those involved and the 
needs of the organisation (Bovey and Hede, 2001).  Therefore, it is vital that the 
change agent communicates and regularly engages with those concerned; this 
allows feedback to be acknowledged and increases the likelihood of embedding the 
change into everyday activities (HSE, 2008). 
Based on this principle, the writer then arranged a meeting with the Health Strategy 
Manager within the organisation. The purpose of the meeting was to communicate 
pharmacist and patient feedback and discuss the implications for the project. In order 
for the integration and embedding of change to be possible, lessons learned, and 
dissemination of best practice is crucial (Shigayeva and Coker, 2014). As pharmacist 
and patient time were a prevalent threat to future sustainability, the following 
changes were agreed.  
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Change Process Outcome 
Reduce the time it takes to run 
an asthma clinic. 
All new asthma patients will 
receive a “Know your 
medicines” questionnaire. 
Asthma patients will automatically 
be given a questionnaire- asthma 
clinics were deemed too time- 
consuming. 
Develop a way to identify 
existing asthma patients.  
Generate a patient report on the 
dispensary system and develop 
a three- month plan to approach 
each patient. 
This will incorporate the 
questionnaire into daily pharmacist 
activities using a realistic 
timeframe.    
 
The questionnaire not restricted 
to pharmacist use. 
Pharmaceutical technician 
trained to complete the 
questionnaire with patients.  
The pharmacist will be consulted 
to offer advice and counselling- 
time will be saved in completing 
the questionnaire. 
 
 
Evaluating and Learning  
At this stage of the change process, the writer changed their focus to reflect on the 
change process and to acknowledge positive and negative aspects related to such. 
Evaluation is a formal method of identifying learnings and is deemed valuable in 
reviewing the change process and determining aspects that require further 
development or variation (HSE, 2008).  
With this in mind, the writer communicated and regularly engaged with key 
stakeholders throughout the project and on completion. The feedback obtained 
through these discussions was a paramount factor in refining the process and 
establishing best practice for the future.  Concerning future sustainability, methods of 
evaluation should be in place and directly aligned with the change strategy (Epstein 
Roy, 2001). The following chapter presents the evaluation methods and results.  
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Conclusion 
The aim of this change project was to improve patient knowledge, adherence and 
use of their medicines through the introduction of a patient-centred service in 
community pharmacy. The writer reviewed various change models before deciding 
on the HSE model of change. This change model provided a comprehensive 
framework for implementing the change and included the use of various analytical 
tools such as SWOT, PEST, stakeholder, force field and stakeholder analysis. The 
use of these tools helped to inform the project and also provided data to persuade 
key stakeholders towards change. The final stage of this chapter concluded with a 
brief overview of the evaluation. This will be discussed in greater detail in the 
following chapter, chapter four.  
4.0 Evaluation  
4.1 Introduction: 
While all change improvements require change; the key to successful change is 
evaluation. Evaluation encourages managers to ascertain the value of an 
intervention through the collection and examination of data (Øvretveit, 1998) and 
then deciding on areas for review and development (HSE, 2008). In the context of 
this change project, it was imperative to identify if the project worked well before 
replicating it on a more considerable scale. As discussed in chapter three, this 
improvement effort was implemented in four pharmacies and would be considered 
for a full organisational roll out if successful. This chapter is directly linked with the 
objectives outlined in chapter one of this dissertation.  
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4.2 Significance of Healthcare Evaluation: 
It is extensively recognised that an understanding of evaluation is essential for health 
care professionals; those involved in healthcare delivery must evaluate their area of 
practice to ensure patients receive high -quality care. Moreover, continuous 
improvement and development of health services should be of high importance and 
embedded into routine practice(HSE, 2008).This has become paramount in recent 
years due to inconsistency in care provision, rising healthcare costs and increased 
emphasis on patient satisfaction (Conry et al., 2012). In the context of healthcare 
improvement, evaluation should consider the entire intervention from engaging with 
the patient to the expected changes in processes and outcomes (Parry et al., 2013; 
Donabedian, 2005).Therefore, the mechanisms for evaluation should be resourced 
appropriately and be in place at each stage of the improvement process (HSE, 
2008).  
 
4.3 Evaluation:   
Numerous definitions of evaluation exist; many refer to Program and policy 
evaluation, others relate to improvement and results evaluation (Kahan, 2008). 
Lazenbatt (2002) describes evaluation as “a method of measuring the extent to 
which an intervention has achieved its stated objectives”. In healthcare, the stated 
objective is often an improvement in patient care through clinical intervention or 
improved service delivery. It is now recognised that improvement initiatives in patient 
care should be subject to evaluation to ascertain their effectiveness and in economic 
evaluations, their efficiency (Gerrish and Mawson, 2005).There are various 
approaches to healthcare evaluation. It is, therefore, imperative that the methods of 
evaluation employed are appropriate and aligned with the objectives of the 
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intervention. With this in mind, the writer reviewed various evaluation tools before 
deciding on the most suitable model to evaluate the project.  
Evaluation Models 
The CIPP (Context, Input, Process, and Product) model was developed by Daniel 
Stufflebeam in the 1970s’. This model provides a comprehensive framework for 
guiding formative and summative evaluation that deems it appropriate at the 
beginning and on completion of a project (Frye & Hemmer, 2012; Kealey, 2010). The 
non-linear design and flexibility of the model allows it to be used in a variety of 
educational and non-educational settings. However, this model requires careful 
planning and multiple sets of data collection are required to use it successfully. 
Hence; the writer believed this model would be too time- consuming for the context 
of this project. Similarly, Jacobs’ ten stage model considers the complexities of 
evaluation and allows the evaluator to adapt and modify their approach at each 
stage (McNamara et al., 2010). While, the writer, appreciated the non-linear and 
objective focused design; they omitted this model due to the complex evaluation 
process associated with such. Comparably, Kirkpatrick’s four-level model is 
extremely agile and can be modified to suit various scenarios. However, unlike the 
other two models the writer considered the clarity of the model and its transparent 
focus on educational outcomes (Frye & Hemmer, 2012). Consequently, the writer 
believed this model was the most suitable to evaluate their project. 
Kirkpatrick Model: 
Kirkpatrick’s four- level evaluation model remains the standard evaluation model for 
industry and business.It has made vast contributions to educational evaluation 
through its clear focus on learner behaviour in the context for which they are trained 
(Frye & Hemmer, 2012). The model not only considers learner satisfaction and 
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response to the program; actual behavioural changes in the learner and final results 
are also evaluated (Bates, 2004). The subsequent figure presents Kirkpatrick’s 
evaluation model. 
 
 
Figure three: Kirkpatrick Model 
 
4.3.1 Aims: 
The aim of the evaluation methods in this project was to ascertain whether the 
results successfully corresponded with the objectives outlined in chapter one. 
Moreover, the writer wanted to gain further insight into the project so that an 
expansion of the project would be effective and practical. In the next section, the 
writer will discuss the methods and measures of evaluation employed during the 
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evaluation period. Kirkpatrick’s model of evaluation was used to evaluate the 
educational aspects of the change project. 
4.3.2 Methods and Measures: 
Objective one: To gather qualitative and quantitative data through a “know 
your medicines” questionnaire. This will inform through analysis; process and 
behavioural changes that will lead to an improvement in patient care. 
The objective was to improve the way pharmacists’ engage with patients’ through the 
introduction of a patient-centred service. The writer evaluated the participation rate in 
the four pharmacies through measuring the quantity of completed adherence 
questionnaires and gauging the reaction and behaviours of both pharmacists and 
patients. The writer believes this aspect of the objective was achieved, fifteen 
questionnaires were completed, and there was a 100% participation rate.  
Level 1 – Reaction: 
The aim of this level was to quantify how participants felt; the writer measured this 
through the process of qualitative analysis. An evaluation of verbal reaction was 
assessed using a series of informal interviews. On completion of each asthma clinic, 
the writer took the time to ask participants how they felt about the new process. This 
was an informal method in which three key questions were asked. Interviews, 
according to Fontana and Frey are “one of the most common and powerful ways we 
try to understand our fellow human beings” (as cited by Denzin and Lincoln, 1998, 
p.47).  
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Table 1 below outlines an example of the questions used by the writer. 
Question 1:  Did you feel the questionnaire was beneficial? 
Question 2:  Did you enjoy participating in the project? 
Question 3:   How did the questionnaire benefit you? 
Table 1: Reaction evaluation questions 
Informal interviews were chosen due to accessibility and proximity to the core 
participants, in this case, pharmacists and patients. Informal interviews can also be 
extremely valuable as “social cues, such as voice, intonation, body language, etc. of 
the interviewee can give the interviewer a lot of extra information” (Opendakker, 
2006, P.1) However, this method of evaluation is not without limitations. The 
interviewer can often influence the participant and lead them to a certain direction 
without realising it, thus creating a bias in the data collection (Boynton, 2004). With 
this in mind, the writer made a conscious effort to avoid leading the participants and 
encouraging them to answer in their words.  
To ensure accuracy and precision of information, the writer recorded the interviews 
with uncomplicated note-taking; this method is the most traditional and accepted 
method for capturing interview data (Zhang & Wildemuth, 2009). However, the writer 
was cognizant of collecting data through this method as according to Fontana and 
Frey (2005), note-taking may disrupt the general flow of conversation. With this in 
mind, the writer made brief notes during the interview and then completed a more 
detailed report directly after each interview.  
Both pharmacists’ and patients’ expressed a positive response in relation to the new 
service. Pharmacists appreciated the new variety to their role and the opportunity to 
engage with their patients. Through this new process, they were able to ascertain the 
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actual patient diagnosis, and resolve the incorrect use of medicine. Patients valued 
the opportunity to spend time with their pharmacist; it allowed them to ask questions 
relating to their medicines and also to address any concerns. However, the writer 
was conscious that this initial reaction may not be sustained. According to Yardley & 
Dornan (2011), this type of evaluation encourages general assumptions and is only 
suited to short-term designs. Therefore, it was essential to gauge reaction 
continuously so that sustainability of the change process was more likely. 
Level two- Learning 
Evaluation of pharmacist learning: 
Learning evaluation is the measurement of the increase in knowledge and capability, 
before and after training. In the context of pharmacist learning, the writer evaluated 
their use of the questionnaire following training. This was conducted through 
observation. This allowed the writer to acquire first- hand information that did not 
depend on second- hand reports. Additionally, one of the key advantages of 
observation is its straightforwardness. According to Robson (2002) you do not have 
to spend time interviewing participants to gain insight, “you simply watch what they 
do and listen to what they say” (p.191). Moreover, according to Johnson and 
Onwuegbuzie, (2004) it is common to become over reliant on questionnaires to 
reveal information. Hence, the use of observation evaluation in this context gave the 
writer greater insight into participant capability. However, as the participants being 
observed were the writers’ colleagues it was imperative to avoid observational bias.  
According to Bryman & Bell, (2011) this can affect the validity of the observation.The 
writer avoided this by maintaining an objective approach and avoiding 
generalisations.  
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At baseline, the pharmacists’ would not have utilised structured questionnaires to 
obtain information from patients’. Their initial approach would have been to offer the 
questionnaire without any consultation; it was, therefore, essential that each 
pharmacist was trained to conduct the questionnaire appropriately and to the same 
standard. After the training, their knowledge had improved immensely. This was 
evident through observing their level of capability and efficiency when using the 
questionnaire. It was also apparent that their level of competence developed further 
as they completed several questionnaires. 
Evaluation of patient learning: 
The underlying purpose of the “know your medicines” questionnaire was to improve 
adherence to prescribed medicine through improving patient knowledge. This was 
evaluated by comparing Likert data.  
The questionnaire was used to establish the patients’ baseline knowledge in relation 
to their condition and medication usage. At baseline, the majority of patients’ 
participating in the project did not fully understand their condition or the function of 
their medication. In order to improve their baseline level of understanding, each 
patient was offered a single education session provided by their pharmacist. Each 
session included inhaler technique demonstration and information to encourage self-
management. A review questionnaire was completed eight weeks later to measure 
the impact on patient learning. The following graphs present the baseline level of 
knowledge expressed by patients. 
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Figure Five: Likert scale results pre-intervention 
 
 
Figure six: Likert scale results pre-intervention 
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discussed in chapter three; this change required a cultural change to the behaviours 
of both pharmacists’ and patients’. It was vital that participants would not revert to 
comfortable behaviours once the initial change project was over. This behaviour is 
commonly referred to as the “hawthorn effect”, where individuals change or improve 
on an element of their behaviour in response to their awareness of being observed 
(Holden,2000).  
It was, therefore, imperative to acknowledge the achievement of the change process 
(Kotter, 1995). and to also consider that organisations will continue to change; 
managers must provide clear lines of accountability and responsibility to promote 
sustainable change (HSE, 2008). Furthermore, according to Bird & Cassell (2013) 
behavioural evaluation is less easy to quantify; observation and interviews are 
required on an ongoing basis to reduce a subjective result.  
However on observation, patient engagement did improve after the initial project. 
Pharmacists’ continued to connect and liaise with the patients’ involved.There 
seemed to be a genuine interest in how the patient was progressing post -
intervention and this consequently led to the patient having a more proactive interest 
in their health. 
Furthermore, out of the four participating pharmacists; all four provided the writer 
with recommendations for future use of the questionnaire, one pharmacist had also 
arranged to use the questionnaire in another healthcare setting. This particularly 
satisfied the writer as it was a reflection of sincere interest and buy-in. 
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Level Four- Results 
Results evaluation is the effect on the organisation or environment resulting from the 
improved performance of the trainee.  The aim of this level was to measure the 
quantifiable aspects of organisational performance. Although the percentage of 
prescription items did not increase within the time-frame of the project; a new service 
that added significant value to patient care was successfully implemented in four 
community pharmacies. This aim was achieved by the collective behavioural change 
of pharmacists as a result of training; the target of fifteen questionnaires in four 
pharmacies was achieved which proved the training worked. The service also 
encouraged retention of customers that led to repeat prescription items. This was 
evaluated using a repeat patient tracker recorded by the pharmacists involved 
(Appendix x). Of the fifteen patients participating in the project, only one did not 
return in February and March.  
Objective two: To encourage repeat prescription customers to return to the 
organisation. The target has been set at a 2% increase in prescription items.  
An associated objective of this service was to increase prescription items for the 
organisation through improving adherence to medicine. The writer evaluated this 
objective by performing a profit enquiry on the pharmacy dispensing system; the 
report gave prescription item details pre and post intervention. A profit enquiry was 
generated in January and in March to compare results. This objective was not 
achieved within the duration of the project.  
Through analysis, the results revealed patients collected their medication every 
month despite not using it appropriately. This result correlates with the Pfizer report 
reviewed by the writer in chapter one as non-adherence “has major implications as 
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much expenditure is in effect being wasted on medicines that are not being taken at 
all or taken incorrectly” (IPU Pfizer IPA, 2014). 
However; the result of this objective is a representation of patients’ eligible for the 
GMS General Medical Services Scheme (GMS) scheme. Therefore, in the context of 
this sample size, the cost of medication was not an issue. The writer would maintain 
that the sample size and duration of the project may have affected this result. Further 
implementation of the project and a more continued effect on medication adherence 
should impact prescription items positively.  
Objective three: To improve the rate of non-adherence by changing the 
process in which pharmacists engage with patients. 
The objective was to measure if the percentage of medication adherence increased 
as a result of patient education and counselling. Patients were invited to complete 
the “know your medicines” questionnaire pre and post intervention; this allowed the 
writer to compare questionnaire results. 
Integral to the evaluation of this objective was the validity of data. According to 
Cohen et al. (2007) validity of data is a fundamental aspect of effective research. If 
the data is invalid, then it is deemed insignificant, he maintains that the use of 
suitable instrumentation may improve quantitative data validity.  
As discussed in chapter three, a Likert scale method was chosen as it is the most 
commonly used method for measuring attitudes and therefore highly likely to provide 
a reliable result (Boynton, 2004). However, this method of evaluation is not without 
limitations; quantitative research has the potential for standard error and can be 
subjective to bias (Cohen et al., 2007). In order to enhance validity and decrease 
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invalidity, the writer piloted the questionnaires before rolling the questionnaire out to 
the four pharmacies. After the pilot, Likert scale questions were addressed due to 
lack of clarity and confusion.  Further to this, Boynton (2004) recommends using a 
previously validated questionnaire. With this in mind, the belief in medicines 
questionnaire (BMQ) and the new medicines version used by the NHS were 
referenced by the writer during the design stage and before implementation.  
The questionnaire used at baseline has been described in detail in chapter three. 
Related questions were used at baseline and after eight weeks (Appendix); this 
allowed the writer to compare data and assess the impact of patient engagement on 
medication adherence. The questionnaire was designed to measure the patients’ 
use of medication and their likelihood to be adherent. The subsequent graphs reflect 
the level of patient adherence at baseline. 
 
Figure Five-Likert Scale Result Pre-Intervention 
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Figure Six-Likert Scale Result Pre-Intervention 
Objective Four: The questionnaire will be rolled out to four pharmacies before 
the end of January 2015 as a trial project.   
The objective was to roll out the “know your medicines” questionnaire in four 
pharmacies before the end of January 2015. This objective was achieved entirely 
and the details associated with such are presented below in Table 2. 
 
Pharmacy Implementation date Achieved 
Pharmacy A 20-January-2015 Yes 
Pharmacy B 21-January-2015 Yes 
Pharmacy C 22-January-2015 Yes 
Pharmacy D 23-January-2015 Yes 
Table 2: Summary of implementation 
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4.3.3 Results:   
The subsequent bar charts present the data collected post- intervention.  The 
increase in medicines adherence increased significantly as a result of pharmacist 
intervention. 
Validity and Reliability of data: 
Validity refers to the appropriateness, as well as accuracy of data Cohen (2007).  
Reliability, on the other hand, refers to the concept that if the change project were 
conducted in another setting the results would be similar or different (Cohen et al., 
2007). The writer is aware that this change project is reflective of a small sample size 
so is not without limitation. Hence, the results below are valid for the context of this 
project only. However, further dissemination of the questionnaire and service would 
further substantiate validity and reliability of results.  
 
Figure Seven-Likert Scale Result Post Intervention 
0
2
4
6
8
Always True Mostly true Not Sure Sometimes
Not True
Never True
5 
8 
0 
2 
0 N
u
m
b
e
r 
o
f 
P
a
ti
e
n
ts
 
Results 
I know everything I need to about my condition 
  
58 
 
Figure Eight-Likert Scale Result Post Intervention 
 
 
 
 
Figure Nine-Likert Scale Result Post Intervention 
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Figure Ten-Likert Scale Result Post-Intervention 
4.3.4 Dissemination plan: 
In terms of implementation, the qualitative evaluation revealed the “know your 
medicines” service was successfully introduced in the four community pharmacies 
involved in the change project. This is further substantiated by the quantitative data 
that revealed an increase in patient knowledge and adherence to prescribed 
medication. Thus, the dissemination of this project to the entire organisation will 
change the current procedures in community pharmacy and influence best practice. 
Through this new practice, pharmacists and patients can share understanding and 
information about medicines and medicine use. This will thereby provide guidance 
and support to patients so that adherence and self- management is more probable in 
their everyday lives. 
Dissemination Aim: 
The dissemination aim is to enhance further patient and pharmacist awareness of 
the service which will lead to an increased contribution to patient care and medicines 
adherence.  
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Target Audiences: 
To achieve this aim, the writer will firstly disseminate the data to the senior 
management team (SMT) within the organisation. Once their “buy-in” is achieved, 
the remainder of the target audience can be considered, in this case, pharmacists, 
patients and GPs’. 
Key messages and communication plan: 
The key communication to stakeholders will include the positive impact of the 
project; this will be conveyed through the positive results in relation to patient 
adherence and patient care. The organisation currently consists of eighty- seven 
pharmacies; hence the dissemination of data to all pharmacies would be an 
immense undertaking for the writer alone. With this in mind, the writer intends to 
identify change champions within the organisation; this will encourage a more 
practical roll- out of the service and a higher likelihood of project sustainability.  
Various sources of communication will be employed to ensure the transfer of data is 
effective. The organisations’ monthly bulletin will be used as a medium to 
disseminate  the success of the project to pharmacists and pharmaceutical 
technicians. This will enhance their understanding of the service and prepare them 
for future roll out led by a change champion in each area. A manual detailing a 
summary of findings and guidance in carrying out the service will also be made 
available. 
 4.4 Summary and Conclusion: 
The writer used a mixed method approach to evaluate the dissemination of the 
“know your medicines” service to four community pharmacies. The use of 
Kirkpatrick’s model in objective one ensured all aspects of the educational evaluation 
were considered. The aim of the evaluation methods employed in this chapter was to 
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ascertain the effectiveness of the questionnaire concerning organisational impact, 
patient- centred care and medicines adherence. Various qualitative and quantitative 
methods were included to ensure a comprehensive evaluation; this involved 
observation, informal interviews, and Likert scale data analysis.  
This method is also described as triangulation which is defined by Robson (2002) as 
a means of using multiple methodologies to gain information on a chosen field. 
Denscombe (2010) further built on this by stating, triangulation can provide the 
evaluator with various perspectives on the data collection. Therefore, the accuracy, 
validity and reliability of data will improve. 
For the most part, the writer is confident that the evaluation results reflect 
achievement of set objectives. Although prescription items did not increase within the 
time-frame of the project, medicines adherence did. The writer believes this will 
impact prescription item revenue in the future. The subsequent chapter, chapter five 
will explore the findings and suggest further recommendations. 
Chapter Five: Discussion and Conclusions 
5.1 Introduction 
As detailed in chapter four, the overall aim of the project was successfully achieved. 
Through the introduction of the “Know your Medicines” service, patient engagement 
improved, and the rate of adherence to prescribed medication increased. This 
chapter provides further detail on the findings from the project; the implications of the 
project for stakeholders and the related strengths and limitations. It also identifies 
areas for improvement and presents future recommendations.   
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5.2 Project Impact 
The change had a positive influence on patient- centred care. Through increased 
interaction between the pharmacist and patient; patient engagement, patients’ 
understanding of medicines and patients’ medicines adherence improved. The 
change also led to the development of pharmacists’, this project encouraged those 
involved to apply further their clinical knowledge and counselling skills which had a 
positive effect on the advancement of pharmacist practice.  
5.2.1 Stakeholders 
 Despite initial resistance from pharmacists’ participating in the project, the 
initiative was succeeded and consequently created a sense of achievement 
amongst staff. Further detail on initial resistance is detailed in reflection one of 
this dissertation. The change project allowed pharmacists’ to develop their 
relationships with patients’ and consequently enhanced their confidence.  
 The feedback from patients was especially promising as the majority found 
the “know your medicines” service highly valuable. It provided them with an 
opportunity to discuss their medicines and to acquire the skills and knowledge 
to effectively manage their condition. An improvement in self-management 
skills was shown at the follow-up review. The subsequent statements capture 
the project impact on patient well-being; 
Patient A: “ I feel like a new woman, I can breathe again.” 
Patient B:  “ I have been using inhalers for years, and this is the first time I 
have been shown how to use them properly.” 
Patient C: “ As a result of the service, I now understand why I’m taking my 
medicines.”  
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  As part of the organisations ongoing focus to encourage repeat customers 
and improve the health and well-being of patients; it was decided by senior 
management to continue this service. Senior management has recommended 
that the service be fully implemented over the coming three months. It will 
also be provided to new asthma patients’ on an ongoing basis.  
 The writer successfully implemented a new service within the organisation; 
this enhanced their level of confidence and also made them more aware of 
their managerial strengths and weaknesses. On completion of the change 
project the writer reflected on their behaviour throughout the change process; 
this is documented in the main reflection piece that accompanies this 
dissertation.  
5.2.2 Practice  
The primary aim of this change was to improve adherence to prescribed medication 
through improved advice and counselling. The project required a cultural change to 
the current practice of community pharmacists and the organisation. As discussed in 
chapter one, community pharmacies have been affected by considerable cuts in fees 
paid by the HSE through the Financial Emergency Measures in Public Interest 
(FEMPI) Act, 2009. This led to the shift from a margin model to a volume model that 
created an increase in workload and a decrease in resources. Consequently, patient 
engagement proved more challenging for community pharmacists’; this change 
sought to improve and develop pharmacy practice through the introduction of the 
“know your medicines” service. The aim of this change was successfully achieved 
through the delivery of the change process and through addressing each objective 
collectively. The introduction of the “know your medicines service” improved the 
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communication and engagement between pharmacists’ and patients’ thus reducing 
the rate of non-adherence and improving health outcomes. 
 The service has encouraged an improvement in patient self- management 
through an increase in education, communication and health coaching. 
 It has influenced a change in the current culture of pharmacy through 
changing the process in which pharmacists’ and patients’ engage; the service 
encouraged reflection, note-taking and improved collaboration.  
Pharmacist morale was enhanced as they appreciated the opportunity to use their 
clinical knowledge and add variety to their role.  
5.2.3 Theory 
Prior to commencing the change process, the writer completed a literature review 
that focused primarily on patient centred care. In particular, the review focused on 
the rationale behind the change to NHS community pharmacy contracts in 2005, 
which sought to reward more patient-centred services. The review, which is detailed 
in chapter two of this dissertation, encouraged the execution of this project through 
outlining the advantages of patient -centred services and also the obstacles 
associated with such. The information gathered through the literature review helped 
to inform the writers’ thinking; this was particularly significant in determining the 
change methodologies that are discussed in chapter three. The writer had initially 
considered the implementation of the service to all patients; however the evidence 
detailed in previous studies promoted the dissemination to one patient cohort initially.  
On completion of the change process, the writer analysed the correlations between 
the outcomes of their change project and the findings from previous papers. 
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Patient- Centred Care: 
The principal objective of this project was to prove patient engagement has an 
impact on medicines adherence and the overall quality of care. The literature was 
essentially in favour of this hypothesis. The majority of studies reviewed found that a 
collaborative approach to healthcare will have a positive effect on medicines 
adherence and health outcomes (Gruman et al., 2010), (Coulter, 2006), (Greenall, 
2006). However, this contrasts with the views held by Albekairy (2014) and Coulter 
and Ellins (2007) in that patient -centred service such as medicine use reviews are 
not feasible due to lack of patient interest and time. The results of this change project 
challenged those views as the writer had a 100% participation rate from patients’ and 
pharmacists’ involved in the initiative. While the writers’ thinking is in favour of the 
literature supporting patient- centred services, it would be idealistic to make this 
conclusion based on their sample size and project time-frame. Moreover, the 100% 
participation rate could have been correlated with the relationships between the 
writer as the change agent and their colleagues as participating pharmacists’. 
Hence, further research is required in this area. 
 
Medicines Adherence: 
As presented in the previous chapter and on figure six and nine, of the fifteen 
patients’ participating in the change project the probability to be adherent did 
increase. At baseline the amount of patients’ that answered always true to the 
question; “I take my medicine regularly when I’m supposed to” resulted in zero, this 
increased to eight post -intervention. Comparably, similar studies carried out by Lee 
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et al. (2006), and Mikkonen (2012) show the correlations between patient education 
and medicines adherence which led the writer to anticipate a positive outcome.  
While the writer was reassured by this outcome, and the correlation with the 
literature. It would be impractical to disregard the difficulty of sustainability that is a 
common theme within similar studies referenced in chapter two (Greenall, 2006), 
Lee et al. (2006). It is apparent in these studies that the level of adherence did 
improve, but only for the duration of the trial. With this in mind, the writer has based 
aspects of their future recommendations to facilitate project sustainability. 
 
5.3 Strengths of the Project 
The main strength of this project was in the participants, without the collective 
involvement of pharmacists’ and patients’ it would not have been possible to 
implement the service. The writer depended on the pharmacists’ advice and 
expertise in community pharmacy to successfully disseminate the questionnaire to 
patients.  
However, if the project had not been approved by senior management; staff may not 
have been as willing to assist in the change process. The support from senior 
management created a “sense of urgency” which according to Kotter (1995) is 
essential to change management. Endorsement from senior management also 
influenced the level of power the writer had as a change agent. This was highly 
significant as it is power that encourages individuals to do something in a particular 
way; and it is also power that maintains many structures and processes (Diefenbach, 
Todnem By and Klarner, 2009). 
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Although, according to Handy (1993) “possession of a power source does not 
automatically mean that you can influence someone” p125. It was imperative to 
consider this during the change process as not all approaches to power lead to the 
desired effect. If senior management had initiated the service in a coercive manner, 
pharmacists might have been more likely to simply comply rather than cooperate 
(Handy, 1993).With this in mind, the writer decided on a more persuasive power 
base. Considering the organisations’ culture and the context of the change, it was 
more appropriate to influence participants using expert power (Bowditch and Buono, 
1997).  
Additionally, the New Medicines Service version provided by the NHS in the UK had 
already been established so provided a benchmark for reference in the design and 
implementation phase. Its success also provided evidence to influence the 
organisation and employees towards change. 
5.4 Limitations 
However, the writer is aware that this project was not without limitations. Patients’ 
adherence to medicines is particularly difficult to measure (Jose, 2011).The method 
used in this project was self -reported adherence. This was measured by comparing 
the initial “Know your Medicines” questionnaire with an eight week follow- up 
questionnaire. As discussed in chapter four, every effort was made to ensure validity 
of data. However, the writer is aware that this will never be 100% possible as 
according to Cohen (2007) there are several areas where invalidity may still be a 
consequence. Despite reducing these aspects through preventing non-return of 
questionnaires and avoiding too long or too short between questionnaire one and 
questionnaire two a certain percentage of invalidity is inevitable (Cohen, Manion & 
Morrison, 2003). 
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Time was also another fundamental limitation; it was difficult to measure project 
sustainability within the allocated time-frame. However, as the organisation has 
agreed to disseminate further and develop this change, the writer is hopeful that 
sustainability of the service is likely. 
The management style displayed by the writer is also noted as a limitation.This style 
of management is further discussed by the writer in the main reflection piece that 
accompanies this dissertation. The level of support provided to the participants 
during the change process would not be viable if the project were replicated on a 
wider scale. Hence, the leadership style displayed by the writer would be described 
as situational. While the writer had a vision, which according to Dubrin (2010) is a 
principal aspect of successful leadership; the change process was over-managed 
and under-led at various stages. As discussed in chapter three of this dissertation; 
the writer attended and assisted the pharmacists’ at each asthma clinic. While this 
approach was successful within the context of the project, it is believed true 
leadership should not just focus on the leader. Leadership should also focus on the 
followers, peers and supervisors within an organisation. An increase in delegation 
and responsibility allows for more strategic thinking and leadership effectiveness. 
(Avolio &Walumbwa et al., 2009, pp. 421-449). 
 
5.5 Recommendations  
Consequently, the writer recommends the need for change champions. Kotter (1995) 
refers to this as empowering others to act on the vision. As this will encourage 
employee engagement and participation, the writer will be able to replicate the 
change to other pharmacies using a more realistic approach.  
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Supervising Pharmacists’  will be empowered to take the lead in this service and 
disseminate to all existing asthma patients’ over a three- month period. The 
questionnaire will also be distributed to new asthma patients’ on an ongoing basis. 
Furthermore, one of the foremost recommendations for future development is to 
adapt the “know your medicines” service so that it is more asthma-specific. The 
development of the questionnaire was initially designed to suit patients commencing 
on a new medicine or patients prescribed more than four medicines. However, it 
became evident during the initial pilot that this approach was too broad and, 
therefore, difficult to execute and evaluate.  The writer has recommended a change 
in name to the service so that it will attract more asthma patients, “asthma control” 
has been proposed to senior management. 
Additionally, the writer strongly recommends patient referral from other healthcare 
professionals such as GPs’ and the Asthma Society of Ireland. This is a vital element 
for future sustainability and improved outcomes. Referral of patients’ for this service 
will ensure patients’ that require the service most will be more likely to avail of it. 
Finally, the writer recommends that this service is disseminated to other conditions. 
The New Medicines Service (NMS) provided by the NHS to patients’ in the UK has 
been disseminated to four therapy areas, Asthma/COPD, Hypertension, Type Two 
Diabetes and Anticoagulation therapy (PSNC Main site, 2014).  
 
5.6 Summary and Conclusion 
This organisational development project included the introduction of a patient- 
centred service in four community pharmacies. The design and dissemination of a 
structured questionnaire, and the evaluation of the overall aim to improve medicines 
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adherence through increased patient engagement. The data collection generated 
from the questionnaire used at baseline and post- intervention endorsed the use of 
adherence questionnaires in community pharmacy. Moreover, the overall feedback 
from participants and senior management indicate that the change was effectively 
established and completed. While the “know your medicines” service only 
concentrated on one cohort of patients, the evaluation of patient response revealed 
the need to roll-out to other therapy areas. The time limitations of this project did not 
allow the writer to fully measure the aspect of sustainability. However, the project did 
reveal the improvements to patient care and adherence to medication that will 
generally lead to improved health outcomes.  
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Appendix 1 
Swot Analysis of HSE change model 
SWOT Analysis Template 
Swot analysis of the Health Service Executive Change Model.  
 
 
Strengths 
 Comprehensive 
 Cyclical 
 Collaborative 
 Encourages change agent to reflect 
 Encourages staff engagement  
 Irish model 
 Non-linear 
 Focus on sustainability 
 
 
Weaknesses 
 Repetitive 
 Unclear if you have not used it 
previously 
 Lack of clarity model diagram 
 Lack of associated literature 
 
Opportunities 
 Agile model 
 Opportunity to adapt the model to 
my project 
 Initiation encourages the use of 
tools 
 Continuous 
 
Threats 
 Time to complete each stage 
 Assumes background knowledge 
 Lack of associated literature 
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Appendix 2: 
 
SWOT analysis of “Know your Medicines” change project. 
 
Swot Analysis Template 
SWOT Analysis of the organisational change project.  
 
Strengths 
  
 
 The NHS version can be used to set 
the standard. 
 
 Will allow the pharmacist to assess 
the actual use of medication and 
resolve ineffective use. 
 
 Will improve pharmacist/patient 
engagement. 
 
 Will improve adherence to prescribed 
medication. 
 
 
Weaknesses 
 
 The time to complete the 
questionnaire may hinder the 
success of the project. 
 
 Conflicting projects. 
 
 The accuracy of patient answers 
on the questionnaire. 
 
 
Opportunities 
 Opportunity to introduce a 
patient-centred service. 
 
 To network with key stakeholders, 
GP’s, Asthma Society of Ireland, 
Patients, Pharmacists. 
 
 To become the pharmacy of 
choice for asthma patients.  
 
Threats 
 Sustainability 
 
 Pharmacist/Patient Resistance 
 
 Funding for extra resources 
 
 The value patients put on 
adherence questionnaires. 
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Appendix 3: PEST Analysis  
PEST Analysis of organisational change project 
PEST Analysis 
PEST Analysis of organisational change project 
 
Political 
 Report published in 2014 by 
Pfizer, IPU and IPA revealed non-
adherence is costing EU 
governments an estimated 125 
billion 
Economical 
 Fempi Cuts 
 Reduced margin in pharmacy 
 Potential to increase 
organisational revenue as a result 
of an increase in prescription 
items 
 
Social 
 Increased demand on healthcare 
industry in recent years 
 Public perception of adherence 
questionnaires 
 Improved adherence will impact on 
the amount of re-admissions to 
hospital 
Technological 
 Not all patients are comfortable with 
the use of I.T. 
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Appendix 4: Stakeholder Analysis 
High 
 Patients 
 Pharmacists 
 Senior management team 
 
  Local Doctors 
 Asthma Society 
 
low        Interest                                                        High      
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Appendix 5: Force Field Analysis 
Force Field Analysis 
 
Score 
 
Forces FOR 
Change 
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Company Growth Strategy Patient Interest 
Revenue Potential Lack of Time 
Decreasing Margin Lack of Resources 
Patient Centred Service Value of Service 
Conflicting Projects Improved Adherence 
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Appendix 6: Know Your Medicines window display 
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Appendix 7: Know your medicines Questionnaire
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Appendix 8: Review Questionnaire 
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Appendix 9: Patient Tracker 
 
Patient 
Name 
Start 
Date 
KYM Outcome Review 
Date 
Outcome Returned 
for 
repeat 
Returned 
for 
repeat 
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Appendix 10: Poster
 
